Report for: Zonisamide add-on therapy for focal epilepsy

Title	Zonisamide add-on therapy for focal epilepsy
Published in	Cochrane database of systematic reviews, July 2020
DOI	10.1002/14651858.cd001416.pub5
Pubmed ID	32715463
Authors	Francesco Brigo, Simona Lattanzi, Stanley C Igwe, Masoud Behzadifar, Nicola Luigi Bragazzi

View on publisher site Alert me about new mentions

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country	Count	As %
Unknown	56	100%

Demographic breakdown

Readers by professional status	Count	As %
Student > Bachelor	8	14%
Student > Master	5	9%
Other	4	7%
Researcher	3	5%
Student > Postgraduate	3	5%
Other	4	7%
Unknown	29	52%

Readers by discipline	Count	As %
Medicine and Dentistry	9	16%
Psychology	5	9%
Neuroscience	3	5%
Pharmacology, Toxicology and Pharmaceutical Science	2	4%
Agricultural and Biological Sciences	1	2%
Other	4	7%
Unknown	32	57%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2022.

All research outputs

#20,712,517

of 23,312,088 outputs

Outputs from Cochrane database of systematic reviews

#12,137

of 12,465 outputs

Outputs of similar age

#341,689

of 398,876 outputs

Outputs of similar age from Cochrane database of systematic reviews

#184

of 187 outputs

Altmetric has tracked 23,312,088 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.

So far Altmetric has tracked 12,465 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.8. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 398,876 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.

We're also able to compare this research output to 187 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.

Cochrane Database of Systematic Reviews

Zonisamide add-on therapy for focal epilepsy

Mentioned by

Citations

Readers on

Mendeley readers

Geographical breakdown

Demographic breakdown

Attention Score in Context